Podcast


Presenter: Betsy Thomas BSc. Pharm G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D

Podcast: BS Medicine Episode 548: Do you really need to measure lipoprotein(a) or apolipoprotein B
0:00

In episode 548, James and Mike invite Betsy Thomas back to the podcast to talk about whether or not measuring lipoprotein(a) or apolipoprotein B improves cardiovascular risk prediction in a meaningful way over and above using standard risk factors. Many guidelines are now recommending we should do these measurements but is this an evidence-based recommendation?…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #618: From Nerve Pain to Knee Pain: Gabapentinoids for osteoarthritis

In episode 618, Mike K and James chat with Émélie Braschi who helps us go over, yet again, the evidence for the use of gabapentinoids. This time it is for…
Listen 0.5 credits available

BS Medicine Episode #617: A Whiff of Prevention: Treating Male Partners to Reduce Bacterial Vaginosis Recurrence

In episode 617, Tina and James bring in Caitlin Finley to review the latest trial that attempts to answer the question of does treating male sexual partners of females undergoing…
Listen 0.5 credits available

BS Medicine Episode #616: Taking the “ouch” out of IUD insertion: Can topical lidocaine help?

In episode 616, Tina and James discuss the issue around the evidence for using topical anesthetics to reduce the pain associated with IUD insertion. To help with this discussion, we…
Listen 0.5 credits available

Presenter(s):

Betsy Thomas BSc. Pharm G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Betsy Thomas BSc. Pharm
  • G. Michael Allan MD CCFP
  • James McCormack BSc (Pharm) Pharm D

Spearkers do not have any conflicts of interest to declare.